ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Or

Kahn Swick & Foti, LLC has announced a securities class action lawsuit against Organon & Co. (OGN) on behalf of investors who purchased securities between October 31, 2024, and April 30, 2025. The lawsuit alleges that Organon misled investors by contradicting prior statements about its commitment to its dividend payout, leading to a 27% stock price drop after the dividend was significantly reduced from $0.28 to $0.02 on March 10, 2025. Investors have until July 22, 2025, to file lead plaintiff applications.

Analysis

A securities class action lawsuit has been initiated against Organon & Co. (OGN) following allegations of misleading investors regarding its dividend policy during the Class Period of October 31, 2024, to April 30, 2025. The lawsuit, brought by Kahn Swick & Foti, LLC, centers on Organon's March 10, 2025, pre-market announcement of a drastic quarterly dividend reduction from $0.28 to $0.02 per share. This action directly contradicted prior management assurances that the regular quarterly dividend was a "number one priority" and that the company was committed to its capital allocation strategy through said dividend. The article states that "On this news," referring to the March 10 dividend cut disclosure, Organon's share price subsequently fell by more than 27%, declining from a closing price of $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025. This sharp decline indicates a significant negative investor reaction, further evidenced by a per-ticker sentiment score of -0.9 for OGN. Investors who purchased Organon securities within the defined Class Period have until July 22, 2025, to file lead plaintiff applications to potentially recover economic losses stemming from these alleged violations of federal securities laws.

Key Decisions for Investors

• Investors who acquired Organon & Co. securities between October 31, 2024, and April 30, 2025, should evaluate their legal options concerning the class action lawsuit, noting the July 22, 2025 deadline to file for lead plaintiff status.
• Current and prospective investors should exercise caution, closely monitoring the ongoing litigation's potential impact on Organon's reputation and financial stability, as well as any revised guidance on its dividend policy and overall capital allocation strategy.
• The substantial alteration in dividend policy and the subsequent severe stock price decline underscore the critical need to scrutinize management's forward-looking statements and stated commitments, factoring this demonstrated volatility and potential governance concerns into any investment thesis for Organon.